107 related articles for article (PubMed ID: 19054920)
1. Treatment with high-dose methylprednisolone for hepatic veno-occlusive disease in a child with rhabdomyosarcoma.
Chen IL; Yang SN; Hsiao CC; Wu KS; Sheen JM
Pediatr Neonatol; 2008 Aug; 49(4):141-4. PubMed ID: 19054920
[TBL] [Abstract][Full Text] [Related]
2. High-dose methylprednisolone treatment of hepatic veno-occlusive disease in a child with Wilms tumor.
Akyüz C; CaClar K; Emir S; Büyükpamukçu M
Pediatr Hematol Oncol; 2003 Jun; 20(4):345-9. PubMed ID: 12746168
[TBL] [Abstract][Full Text] [Related]
3. Veno-occlusive disease in a child with rhabdomyosarcoma after conventional chemotherapy: report of a case and review of the literature.
Cecen E; Uysal KM; Ozguven A; Gunes D; Irken G; Olgun N
Pediatr Hematol Oncol; 2007 Dec; 24(8):615-21. PubMed ID: 18092252
[TBL] [Abstract][Full Text] [Related]
4. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
[TBL] [Abstract][Full Text] [Related]
5. Severe Hepatic Sinusoidal Obstruction Syndrome in a Child Receiving Vincristine, Actinomycin-D, and Cyclophosphamide for Rhabdomyosarcoma: Successful Treatment with Defibrotide.
Choi A; Kang YK; Lim S; Kim DH; Lim JS; Lee JA
Cancer Res Treat; 2016 Oct; 48(4):1443-1447. PubMed ID: 27034141
[TBL] [Abstract][Full Text] [Related]
6. Veno-occlusive disease in pediatric patients receiving actinomycin D and vincristine only for the treatment of rhabdomyosarcoma.
Sulis ML; Bessmertny O; Granowetter L; Weiner M; Kelly KM
J Pediatr Hematol Oncol; 2004 Dec; 26(12):843-6. PubMed ID: 15591910
[TBL] [Abstract][Full Text] [Related]
7. Hepatic veno-occlusive disease (VOD) with complete occlusion of liver venules after tandem autologous stem cell transplantation-- successful treatment with high-dose methylprednisolone and defibrotide.
Sayer HG; Will U; Schilling K; Vogt T; Wollina K; Höffken K
J Cancer Res Clin Oncol; 2002 Mar; 128(3):148-52. PubMed ID: 11935301
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of hepatic veno-occlusive disease after myeloablative allogeneic hematopoietic stem cell transplantation by early administration of a short course of methylprednisolone.
Al Beihany A; Al Omar H; Sahovic E; Chaudhri N; Al Mohareb F; Al Sharif F; Al Zahrani H; Al Shanqeeti A; Seth P; Zaidi S; Morshed M; Al Anazi K; Mohamed G; Gyger M; Aljurf M
Bone Marrow Transplant; 2008 Feb; 41(3):287-91. PubMed ID: 17982501
[TBL] [Abstract][Full Text] [Related]
9. Veno-occlusive disease (VOD) of the liver in Korean patients following allogeneic bone marrow transplantation (BMT): efficacy of recombinant human tissue plasminogen activator (rt-PA) treatment.
Lee JH; Lee KH; Choi JS; Zang DY; Kim SB; Kim SW; Suh C; Lee JS; Kim WK; Lee YS; Kim SH
J Korean Med Sci; 1996 Apr; 11(2):118-26. PubMed ID: 8835758
[TBL] [Abstract][Full Text] [Related]
10. Veno-occlusive disease in a male patient with Marfan syndrome and common acute lymphoblastic leukemia during induction therapy.
Kraemer DM; Waschke J; Kunzmann V; Wilhelm M
Ann Hematol; 2003 Jul; 82(7):444-7. PubMed ID: 12761649
[TBL] [Abstract][Full Text] [Related]
11. Hepatic veno-occlusive disease accompanied by thrombotic microangiopathy developed during treatment of juvenile dermatomyositis and macrophage activation syndrome: A case report.
Mouri M; Kanamori T; Tanaka E; Hiratoko K; Okubo M; Inoue M; Morio T; Shimizu M; Nishino I; Okiyama N; Mori M
Mod Rheumatol Case Rep; 2023 Jun; 7(2):404-409. PubMed ID: 36416547
[TBL] [Abstract][Full Text] [Related]
12. Veno-occlusive disease in pediatric patients affected by Wilms tumor.
Cesaro S; Spiller M; Sartori MT; Alaggio R; Peruzzo M; Saggiorato G; Bisogno G
Pediatr Blood Cancer; 2011 Aug; 57(2):258-61. PubMed ID: 21246705
[TBL] [Abstract][Full Text] [Related]
13. Non-activated protein C rescue treatment in Wilms tumour associated hepatic sinusoidal obstructive syndrome.
De Leonardis F; Koronica R; Bruno SD; Santoro N
Pediatr Blood Cancer; 2014 May; 61(5):940-1. PubMed ID: 24281860
[TBL] [Abstract][Full Text] [Related]
14. Veno-occlusive disease of the liver following high-dose chemotherapy and autologous bone marrow transplantation in children with solid tumors: incidence, clinical course and outcome.
Brugieres L; Hartmann O; Benhamou E; Zafrani ES; Caillaud JM; Patte C; Kalifa C; Flamant F; Lemerle J
Bone Marrow Transplant; 1988 Jan; 3(1):53-8. PubMed ID: 3048471
[TBL] [Abstract][Full Text] [Related]
15. Hepatic veno-occlusive disease--liver toxicity syndrome after bone marrow transplantation.
Shulman HM; Hinterberger W
Bone Marrow Transplant; 1992 Sep; 10(3):197-214. PubMed ID: 1422475
[TBL] [Abstract][Full Text] [Related]
16. Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.
Corbacioglu S; Kernan N; Lehmann L; Brochstein J; Revta C; Grupp S; Martin P; Richardson PG
Expert Rev Hematol; 2012 Jun; 5(3):291-302. PubMed ID: 22780209
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of hepatic veno-occlusive disease after bone marrow transplantation with recombinant human tissue plasminogen activator (rh-tPA)].
Yoshimi A; Kato K; Maeda N; Matsuyama T; Kojima S
Rinsho Ketsueki; 2000 Feb; 41(2):103-8. PubMed ID: 10723238
[TBL] [Abstract][Full Text] [Related]
18. Use of defibrotide in the treatment and prevention of veno-occlusive disease.
Richardson P; Linden E; Revta C; Ho V
Expert Rev Hematol; 2009 Aug; 2(4):365-76. PubMed ID: 21082942
[TBL] [Abstract][Full Text] [Related]
19. A review of tissue plasminogen activator in the treatment of veno-occlusive liver disease after bone marrow transplantation.
Terra SG; Spitzer TR; Tsunoda SM
Pharmacotherapy; 1997; 17(5):929-37. PubMed ID: 9324182
[TBL] [Abstract][Full Text] [Related]
20. Glutamine and vitamin E in the treatment of hepatic veno-occlusive disease following high-dose chemotherapy.
Goringe AP; Brown S; O'Callaghan U; Rees J; Jebb S; Elia M; Poynton CH
Bone Marrow Transplant; 1998 Apr; 21(8):829-32. PubMed ID: 9603409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]